Amyloid-β peptide-induced extracellular S100A9 depletion is associated with decrease of antimicrobial peptide activity in human THP-1 monocytes

[1]  Sabrina Bréchard,et al.  New insights into the regulation of neutrophil NADPH oxidase activity in the phagosome: a focus on the role of lipid and Ca(2+) signaling. , 2013, Antioxidants & redox signaling.

[2]  Zhangrui Cheng,et al.  Time Course of Defense Mechanisms in Bovine Endometrium in Response to Lipopolysaccharide1 , 2012, Biology of reproduction.

[3]  C. Cotman,et al.  Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study , 2012, Journal of Neuroinflammation.

[4]  R. Kane,et al.  Conformational Differences between Two Amyloid β Oligomers of Similar Size and Dissimilar Toxicity* , 2012, The Journal of Biological Chemistry.

[5]  R. Nussinov,et al.  Antimicrobial properties of amyloid peptides. , 2012, Molecular pharmaceutics.

[6]  J. Gilthorpe,et al.  MRP14 (S100A9) Protein Interacts with Alzheimer Beta-Amyloid Peptide and Induces Its Fibrillization , 2012, PloS one.

[7]  W. Lukiw.  Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer’s disease (AD) , 2012, Expert opinion on emerging drugs.

[8]  Ying Sun,et al.  The down regulation of neutrophil oxidative metabolism by S100A8 and S100A9: implication of the protease-activated receptor-2. , 2012, Molecular immunology.

[9]  Y. Suh,et al.  The Role of S100a9 in the Pathogenesis of Alzheimer’s Disease: The Therapeutic Effects of S100a9 Knockdown or Knockout , 2012, Neurodegenerative Diseases.

[10]  C. Holmes,et al.  Systemic and Central Immunity in Alzheimer's Disease: Therapeutic Implications , 2012, CNS neuroscience & therapeutics.

[11]  I. Parker,et al.  Single-channel Ca2+ imaging implicates Aβ1–42 amyloid pores in Alzheimer’s disease pathology , 2011, The Journal of cell biology.

[12]  George Perry.  Faculty Opinions recommendation of Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria. , 2011 .

[13]  J. Miklossy.  Emerging roles of pathogens in Alzheimer disease , 2011, Expert Reviews in Molecular Medicine.

[14]  J. Miklossy,et al.  Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria , 2011, Journal of Neuroinflammation.

[15]  Y. Hiroshima,et al.  Regulation of antimicrobial peptide expression in human gingival keratinocytes by interleukin-1α. , 2011, Archives of oral biology.

[16]  J. Kang,et al.  Extracellular HIV-1 Tat upregulates TNF-α dependent MCP-1/CCL2 production via activation of ERK1/2 pathway in rat hippocampal slice cultures: Inhibition by resveratrol, a polyphenolic phytostilbene , 2011, Experimental Neurology.

[17]  M. Mattson,et al.  Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease. , 2011, Biochimica et biophysica acta.

[18]  Pierrick Bourgeat,et al.  Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease. , 2011, Brain : a journal of neurology.

[19]  R. Veerhuis,et al.  The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer's disease: neuropathological, epidemiological and genetic evidence. , 2011, Current Alzheimer research.

[20]  I. Parker,et al.  Single-channel Ca 2+ imaging implicates A  1–42 amyloid pores in Alzheimer’s disease pathology , 2011 .

[21]  Ian Parker,et al.  Calcium Signaling and Amyloid Toxicity in Alzheimer Disease* , 2010, The Journal of Biological Chemistry.

[22]  B. Hyman,et al.  The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide , 2010, PloS one.

[23]  Y. Suh,et al.  S100a9 Knockdown Decreases the Memory Impairment and the Neuropathology in Tg2576 Mice, AD Animal Model , 2010, PloS one.

[24]  K. Honjo,et al.  Commentary on the letter for Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease? , 2010, Alzheimer's & Dementia.

[25]  C. Geczy,et al.  S100 Calgranulins in inflammatory arthritis , 2010, Immunology and cell biology.

[26]  M. Wozniak,et al.  Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease? , 2009, Alzheimer's & Dementia.

[27]  Martin Ingelsson,et al.  The Alzheimer's Disease-Associated Amyloid \(\beta\)-Protein Is an Antimicrobial Peptide , 2010 .

[28]  S. Drăghici,et al.  Differential expression pattern of genes encoding for anti-microbial peptides in the fetal membranes of patients with spontaneous preterm labor and intact membranes and those with preterm prelabor rupture of the membranes , 2009, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[29]  V. Thulasiraman,et al.  Use of an antibody-coupled array and mass spectrometry for simultaneous detection of multiple amyloid beta fragments , 2009, Alzheimer's & Dementia.

[30]  K. Honjo,et al.  Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease? , 2009, Alzheimer's & Dementia.

[31]  J. Miklossy.  Alzheimer's disease – a neurospirochetosis , 2008 .

[32]  E. Youngsteadt.  Alzheimer's Risk Factor Also Aids HIV , 2008, Science.

[33]  W. Nacken,et al.  Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis , 2007, Annals of the rheumatic diseases.

[34]  R. Medzhitov.  Recognition of microorganisms and activation of the immune response , 2007, Nature.

[35]  J. Palefsky,et al.  Oxidation of methionine 63 and 83 regulates the effect of S100A9 on the migration of neutrophils in vitro , 2007, Journal of leukocyte biology.

[36]  D. Foell,et al.  S100 proteins expressed in phagocytes: a novel group of damage‐associated molecular pattern molecules , 2007, Journal of leukocyte biology.

[37]  G. Halliday,et al.  Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease , 2006, Neurobiology of Aging.

[38]  R. Kayed,et al.  ERK1/2 Activation Mediates Aβ Oligomer-induced Neurotoxicity via Caspase-3 Activation and Tau Cleavage in Rat Organotypic Hippocampal Slice Cultures* , 2006, Journal of Biological Chemistry.

[39]  A. Baldwin,et al.  S100-mediated signal transduction in the nervous system and neurological diseases. , 2005, Cellular and molecular biology.

[40]  J. Kang,et al.  The Amyloid-β Peptide Suppresses Transforming Growth Factor-β1-induced Matrix Metalloproteinase-2 Production via Smad7 Expression in Human Monocytic THP-1 Cells* , 2005, Journal of Biological Chemistry.

[41]  Suryono,et al.  Calprotectin Expression in Human Monocytes: Induction by Porphyromonas gingivalis Lipopolysaccharide, Tumor Necrosis Factor-α, and Interleukin-1β. , 2005, Journal of periodontology.

[42]  S. Karlsson,et al.  Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to β-amyloid deposition in APP/PS1 double transgenic Alzheimer mice , 2005, Neurobiology of Disease.

[43]  J. Kang,et al.  The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells. , 2005, The Journal of biological chemistry.

[44]  T. Nagata,et al.  Calprotectin expression in human monocytes: induction by porphyromonas gingivalis lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1beta. , 2005, Journal of periodontology.

[45]  I. Thorey,et al.  MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. , 2004, Blood.

[46]  D. Appelt,et al.  Infiltration of the brain by pathogens causes Alzheimer’s disease , 2004, Neurobiology of Aging.

[47]  I. Stříž,et al.  Calprotectin - a pleiotropic molecule in acute and chronic inflammation. , 2004, Physiological research.

[48]  P. Rouleau,et al.  Proinflammatory Activities of S100: Proteins S100A8, S100A9, and S100A8/A9 Induce Neutrophil Chemotaxis and Adhesion 1 , 2003, The Journal of Immunology.

[49]  T. Klockgether,et al.  Neuronal and Glial Coexpression of Argininosuccinate Synthetase and Inducible Nitric Oxide Synthase in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[50]  K. Miyasaki,et al.  Mechanism of extracellular release of human neutrophil calprotectin complex , 2001, Journal of leukocyte biology.

[51]  Y. Suh,et al.  Effects of the β-Amyloid and Carboxyl-terminal Fragment of Alzheimer's Amyloid Precursor Protein on the Production of the Tumor Necrosis Factor-α and Matrix Metalloproteinase-9 by Human Monocytic THP-1* , 2001, The Journal of Biological Chemistry.

[52]  C. Geczy,et al.  IL-10 Up-Regulates Macrophage Expression of the S100 Protein S100A81 , 2001, The Journal of Immunology.

[53]  S. Engel,et al.  Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14 , 2000, Acta Neuropathologica.

[54]  Carolyn L. Geczy,et al.  IFN-γ and TNF Regulate Macrophage Expression of the Chemotactic S100 Protein S100A81 , 2000, The Journal of Immunology.

[55]  K. Xu,et al.  IFN-gamma and TNF regulate macrophage expression of the chemotactic S100 protein S100A8. , 2000, Journal of immunology.

[56]  M. Hartmann,et al.  Myeloid-related Protein (MRP) 8 and MRP14, Calcium-binding Proteins of the S100 Family, Are Secreted by Activated Monocytes via a Novel, Tubulin-dependent Pathway* , 1997, The Journal of Biological Chemistry.

[57]  H. Schluesener,et al.  Expression of the S‐100 proteins MRP‐8 and ‐14 in ischemic brain lesions , 1997, Glia.